Skip to main content
. 2004 Jul 19;2004(3):CD003269. doi: 10.1002/14651858.CD003269.pub2

Lightbody 1978.

Methods Crossover design; each phase 3 days.
Participants  
Interventions 2 interventions: Ipratropium bromide 40µg and Salbutamol 200µg, q.i.d.
Outcomes  
Notes This comparison not analysed, so details not extracted.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Information not available (Cochrane Grade B)